Skip to content
SHM Abstracts | Society of Hospital Medicine Logo
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
Search2020-05-20T12:01:36-05:00
Search
Search by Abstract Number, Title, Keyword, or Authors
Category
Sub-Category

(Optional)

Session Type
Meeting
Search Results for Clostridioides difficile
Oral Presentations
Abstract Number: OP2
CAUSAL EFFECTS OF EMPIRIC ANTIBIOTICS ON RISK OF CLOSTRIDIOIDES DIFFICILE: A TARGET TRIAL EMULATION COHORT STUDY
SHM Converge 2022
Background: Clostridioides difficile infection (CDI) is a common, often nosocomial infection associated with substantial morbidity and mortality. Antibiotics are the most important modifiable risk factor, but empiric antibiotics remain appropriate for many patients with severe acute illness. Which antibiotics minimize the risk of CDI remains an important unanswered question. Because protective equipment and isolation were […]
Abstract Number: A7
SAFETY OF INVESTIGATIONAL MICROBIOTA-BASED LIVE BIOTHERAPEUTIC RBX2660 IN INDIVIDUALS WITH RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION: DATA FROM 5 PROSPECTIVE CLINICAL STUDIES
SHM Converge 2022
Background: Microbiota-based treatments have shown promise to reduce recurrence for recurrent Clostridioides difficile infections (rCDI), but consistent and reliable safety data are needed to support regulatory approvals and broaden patient access. Here we provide cumulative safety data from 5 prospective clinical studies evaluating RBX2660—a standardized, microbiota-based investigational live biotherapeutic—for reducing rCDI. Methods: This analysis included […]
Abstract Number: E6
MICROBIOTA-BASED BIOTHERAPEUTIC RBX2660 IMPROVES CLOSTRIDIOIDES DIFFICILE INFECTION OUTCOMES IN A REAL-WORLD POPULATION: A RETROSPECTIVE STUDY OF USE UNDER ENFORCEMENT DISCRETION
SHM Converge 2022
Background: Recurrent Clostridioides difficile infection (rCDI) is an urgent public health threat. RBX2660 is a standardized, stabilized, investigational microbiota-based live biotherapeutic that has been evaluated in 5 prospective clinical trials. Eligibility criteria in clinical trials are often narrowly defined, excluding broader patient populations. Herein, we report a retrospective analysis of safety and efficacy of RBX2660 […]
Abstract Number: L10
INCIDENCE OF HOSPITALIZATIONS IN ECOSPOR III, A PHASE 3, DOUBLE-BLIND, RANDOMIZED TRIAL IN PATIENTS WITH RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION
SHM Converge 2022
Background: Clostridioides difficile infection (CDI) is a leading healthcare-associated infection causing debilitating diarrhea, life-threatening complications, 20,500 deaths and healthcare costs of up to $5.4 billion annually in the US. The main driver of CDI costs is hospitalizations, and patients with higher CDI recurrence rates have more hospitalizations and emergency department visits and longer hospital stays. […]
Oral Presentations
Abstract Number: OP2
CAUSAL EFFECTS OF EMPIRIC ANTIBIOTICS ON RISK OF CLOSTRIDIOIDES DIFFICILE: A TARGET TRIAL EMULATION COHORT STUDY
SHM Converge 2022
Background: Clostridioides difficile infection (CDI) is a common, often nosocomial infection associated with substantial morbidity and mortality. Antibiotics are the most important modifiable risk factor, but empiric antibiotics remain appropriate for many patients with severe acute illness. Which antibiotics minimize the risk of CDI remains an important unanswered question. Because protective equipment and isolation were […]
  • This Week

  • This Month

  • All Time

  • This Week

  • BLOWING SMOKE: VAPING-ASSOCIATED LUNG INJURY PRESENTING AS ABDOMINAL PAIN
  • A Patient’s Presentation of Persistent Sweet Taste in Her Mouth Leads to a Diagnosis of Small Cell Lung Cancer
  • A CASE OF SKIN NECROSIS CAUSED BY INTRAVENOUS XYLAZINE ABUSE
  • Cannabis Withdrawal Induced Hypertensive Urgency
  • ADDERALL INDUCED ISCHEMIC COLITIS
  • This Month

  • A CASE OF SKIN NECROSIS CAUSED BY INTRAVENOUS XYLAZINE ABUSE
  • BLOWING SMOKE: VAPING-ASSOCIATED LUNG INJURY PRESENTING AS ABDOMINAL PAIN
  • A Patient’s Presentation of Persistent Sweet Taste in Her Mouth Leads to a Diagnosis of Small Cell Lung Cancer
  • Cannabis Withdrawal Induced Hypertensive Urgency
  • ADDERALL INDUCED ISCHEMIC COLITIS
  • All Time

  • PECULIAR PRESENTATION OF VERTIGO IN HYPOTHYROIDISM
  • ADDERALL INDUCED ISCHEMIC COLITIS
  • Bc Powder Causing Intracerebral Bleed: Pitfalls of Overlooking Dosage of Seemingly Innocuous Otc Formulations
  • RECOGNIZING S1Q3T3 FOR WHAT IT IS: A NONSPECIFIC PATTERN OF RIGHT HEART STRAIN
  • A Newborn with Bilateral Shoulder Dimples: Case Report and a Review of Literature
© Society of Hospital Medicine | All Rights Reserved
Page load link
Go to Top